These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36089762)

  • 1. Significance of detecting the levels of miR-29a, survivin and interferon gamma release assay in patients with lung cancer and tuberculosis.
    Sun L; Li H; Fu Q; Hu S; Zhao W
    Adv Clin Exp Med; 2022 Oct; 31(10):1073-1080. PubMed ID: 36089762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on molecular mechanism of MiRNA-29a in promoting proliferation and invasion of non-small-cell lung cancer by inhibiting MTSS1.
    Liu M; Zeng X; Lu YX; Mo YJ; Liao TH; Gan C; Lu XQ
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5531-5538. PubMed ID: 30229825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of T-cell IFN-γ and miR-29a expression during active pulmonary tuberculosis.
    Afum-Adjei Awuah A; Ueberberg B; Owusu-Dabo E; Frempong M; Jacobsen M
    Int Immunol; 2014 Oct; 26(10):579-82. PubMed ID: 24981709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and bioinformatic analysis of miR-29 family, target gene IFN-γ in CD4(+) T cells from subjects with latent tuberculosis infection].
    Yi ZJ; Fu YR; Li JH; Zhang B
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Jul; 47(7):632-6. PubMed ID: 24304957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of
    Angria N; Massi MN; Bukhari A; Djaharuddin I; Jumadi O; Ahmad A; Miskad UA; Ladju RB; Santoso A; Halik H
    Ann Med Surg (Lond); 2022 Nov; 83():104786. PubMed ID: 36389185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4⁺ T cells and peripheral blood from tuberculosis patients.
    Kleinsteuber K; Heesch K; Schattling S; Kohns M; Sander-Jülch C; Walzl G; Hesseling A; Mayatepek E; Fleischer B; Marx FM; Jacobsen M
    PLoS One; 2013; 8(4):e61609. PubMed ID: 23613882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer.
    Yu X; Zhang Y; Cavazos D; Ma X; Zhao Z; Du L; Pertsemlidis A
    Cell Death Dis; 2018 Feb; 9(2):193. PubMed ID: 29416000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between Circulating miR-16, miR-29a, miR-144 and miR-150, and the Radiotherapy Response and Survival of Non-Small-Cell Lung Cancer Patients.
    Bache M; Kadler F; Struck O; Medenwald D; Ostheimer C; Güttler A; Keßler J; Kappler M; Riemann A; Thews O; Seliger B; Vordermark D
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
    Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
    Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer.
    Lv T; Li Z; Xu L; Zhang Y; Chen H; Gao Y
    Acta Biomater; 2018 Aug; 76():257-274. PubMed ID: 29960010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-mediated epigenetic targeting of Survivin significantly enhances the antitumor activity of paclitaxel against non-small cell lung cancer.
    Wang S; Zhu L; Zuo W; Zeng Z; Huang L; Lin F; Lin R; Wang J; Lu J; Wang Q; Lin L; Dong H; Wu W; Zheng K; Cai J; Yang S; Ma Y; Ye S; Liu W; Yu Y; Tan J; Liu B
    Oncotarget; 2016 Jun; 7(25):37693-37713. PubMed ID: 27177222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients.
    Jiang M; Zhang P; Hu G; Xiao Z; Xu F; Zhong T; Huang F; Kuang H; Zhang W
    Mol Cell Biochem; 2013 Nov; 383(1-2):67-75. PubMed ID: 23881177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [TCM Combined Western Medicine Treatment of Advanced NSCLC: a Preliminary Study of mIRNA Expression Profiles].
    Li YB; Lin LZ; Guan JS; Chen CM; Zuo Q; Lin BQ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Sep; 36(9):1076-1081. PubMed ID: 30645846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of the interferon-γ release assay for chemotherapy responses in patients with advanced non-small-cell lung cancer.
    Huang HC; Su WJ; Chiang CL; Feng JY; Huang HY; Lin CH; Lin SH; Cheng CY; Chiu CH
    Lung Cancer; 2018 Jan; 115():64-70. PubMed ID: 29290264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance and diagnostic value of Survivin autoantibody in non-small cell lung cancer patients].
    Ma L; Yue W; Zhang L; Wang Y; Zhang C; Yang X
    Zhongguo Fei Ai Za Zhi; 2010 Jul; 13(7):706-12. PubMed ID: 20673487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines.
    Muniyappa MK; Dowling P; Henry M; Meleady P; Doolan P; Gammell P; Clynes M; Barron N
    Eur J Cancer; 2009 Nov; 45(17):3104-18. PubMed ID: 19818597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of miR-29a in serum of patients with pulmonary tuberculosis and prediction of its function with bioinformatics analysis].
    Fu YR; Yi ZJ; Li JH; Gao KS
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):186-90. PubMed ID: 23856141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-Gamma Release Assay is Not Appropriate for the Diagnosis of Active Tuberculosis in High-Burden Tuberculosis Settings: A Retrospective Multicenter Investigation.
    Kang WL; Wang GR; Wu MY; Yang KY; Er-Tai A; Wu SC; Geng SJ; Li ZH; Li MW; Li L; Tang SJ
    Chin Med J (Engl); 2018 Feb; 131(3):268-275. PubMed ID: 29363640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Common miRNAs between Tuberculosis and Non-Small Cell Lung Cancer: A Critical Review.
    Sheikhpour M; Abolfathi H; Karimipoor M; Movafagh A; Shahsavani M
    Tanaffos; 2021 Mar; 20(3):197-208. PubMed ID: 35382078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.